SelSym Biotech
PrivateLast Round
Seed
Jul 15, 2026
Total Funding Raised
$8.57M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
SelSym Biotech is a biotechnology company developing synthetic platelet-mimetic therapeutics for hemorrhage control and wound healing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Defense Tech
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SelSym Biotech Comparables
Compare SelSym Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hemostatics Pharmaceuticals S.L. | 61% | |
| Melanyze, Inc. | 53% |
SelSym Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 15, 2026 | ||||
| Grant | Apr 16, 2024 | ||||
| Seed | Apr 16, 2024 | ||||
| Grant | Sep 22, 2022 | ||||
| Debt | Jun 1, 2022 | ||||
Grant | Sep 15, 2021 |
SelSym Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| NIH RADx | Grant |
| U.S. Department of War | Grant |
| Persephoni BioSciences | Seed |
| North Carolina Biotechnology Center | Debt |
| National Heart, Lung, and Blood Institute | Grant |
| One North Carolina Small Business Program | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2026
$500K Seed Round raised.
- Jul 16, 2025
Grew 50% QoQ from 6 to 9 employees.
SelSym Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access